Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

HERPET- A Novel PET Imaging Study of HER2 in Breast Cancer — Stella

Home/Breast Cancer/HERPET- A Novel PET Imaging Study of HER2 in Breast Cancer

View on ClinicalTrials.gov

Recruiting

Back to Breast Cancer trials

HERPET- A Novel PET Imaging Study of HER2 in Breast Cancer

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United Kingdom

Imperial College Healthcare NHS Trust, London

Key details

Sponsor

Imperial College London

Collaborators

Medical Research Council, University of Cambridge

Enrollment target

~24 participants

Started

March 2019

Primary completion

March 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Sex

Female only

Last updated August 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.